Insider · CIK 0001645333
Column Group II GP, LP
owner
Files at RAPT (RAPT Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | RAPT RAPT Therapeutics, Inc. | JOther Common Stock | -1,352,008 | - | - | 50,000 | Dec 23, 2024 |
| Dec 23, 2024 | RAPT RAPT Therapeutics, Inc. | JOther Common Stockindirect: See footnote | -1,599,417 | - | - | 0 | Dec 23, 2024 |
| Dec 23, 2024 | RAPT RAPT Therapeutics, Inc. | JOther Warrant (right to purchase)derivative | +1,352,008 | - | - | 1,352,008 | Dec 23, 2024 |
| Dec 23, 2024 | RAPT RAPT Therapeutics, Inc. | JOther Warrant (right to purchase)derivativeindirect: See footnote | +1,599,417 | - | - | 1,599,417 | Dec 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.